Clinical Trial Detail

NCT ID NCT03394885
Title Atezolizumab With Neoadjuvant Chemotherapy for Patients With Newly-Diagnosed Advanced-Stage Ovarian Cancer (AdORN)
Recruitment Recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Duke University
Indications

ovary epithelial cancer

fallopian tube carcinoma

peritoneal carcinoma

Therapies

Atezolizumab + Carboplatin + Paclitaxel

Age Groups: adult senior

No variant requirements are available.